GlassScriptPhysician profile
Ajay Varanasi
NPI 1104982420
$159,546.58
in general payments reported to CMS, 2019-2025
42 companies · $54K in 2025
The $54K reported for 2025 was more than what 96% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $20K · 2021: $2,710 · 2022: $855 · 2023: $18K · 2024: $11K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $31K · Travel and Lodging: $5,568 · Food and Beverage: $4,955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $41,879.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $31,023.50 |
| Travel and Lodging | $5,568.18 |
| Food and Beverage | $4,954.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $51,324.86 | 2019-2025 | Ozempic, Rybelsus, Tresiba |
| Ascendis Pharma Endocrinology INC | $45,025.86 | 2025 | Yorvipath |
| Dexcom, INC. | $35,744.34 | 2020-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Lilly USA, LLC | $9,823.99 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,819.60 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $4,590.93 | 2019-2020 | |
| Abbott Laboratories | $816.74 | 2019-2025 | Freestyle Libre 2 |
| Tandem Diabetes Care, INC. | $312.16 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $204.70 | 2019-2020 | |
| Insulet Corporation | $195.19 | 2021-2024 | Omnipod |
| Sanofi-Aventis U.S. LLC | $178.76 | 2019-2023 | |
| Amgen INC. | $168.59 | 2019-2025 | Evenity, Repatha, Tepezza |
| Alexion Pharmaceuticals, INC. | $129.46 | 2020-2025 | Strensiq |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $90.11 | 2023-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $85.05 | 2023-2024 | Gvoke Hypopen |
| Beta Bionics, INC. | $84.62 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Medtronic, INC. | $80.15 | 2021-2025 | Minimed 780g, Minimed 770g |
| Bayer Healthcare Pharmaceuticals INC. | $65.75 | 2022-2025 | |
| Rgh Enterprises LLC | $63.00 | 2025 | |
| Corcept Therapeutics | $51.44 | 2024-2025 | Korlym |
| Regeneron Healthcare Solutions, INC. | $47.98 | 2019 | |
| Abbvie INC. | $44.21 | 2023-2025 | Synthroid |
| Globus Medical, INC. | $43.23 | 2025 | Senza |
| Ascensia Diabetes Care US INC. | $42.94 | 2024 | |
| Merck Sharp & Dohme LLC | $42.69 | 2019 | |
| Lifescan, INC. | $39.98 | 2023 | |
| Nevro Corp. | $35.87 | 2023-2024 | Senza |
| Sequel Med Tech, LLC | $33.92 | 2025 | Twiist |
| Aimmune Therapeutics, INC. | $27.58 | 2025 | Zenpep |
| Cequr Corporation | $27.15 | 2023 | Cequr Simplicity |
| Renalytix Ai, INC. | $21.00 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Shire North American Group INC | $19.57 | 2019 | |
| Ibsa Pharma INC. | $17.53 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.38 | 2019 | |
| Horizon Therapeutics Plc | $17.13 | 2022 | |
| Valeritas, INC. | $16.82 | 2019 | |
| Companion Medical, INC. | $16.43 | 2019 | |
| Antares Pharma, INC. | $15.28 | 2019 | |
| Vivus LLC | $13.96 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.91 | 2019 | |
| Amarin Pharma, INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Varanasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.